CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Cheplapharm Arzneimittel GmbH is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Cheplapharm Arzneimittel GmbH
Ziegelhof 24
Phone: +49 383439140p:+49 383439140 GREIFSWALD, 17489  Germany Ticker: PCPHPCPH
Business Summary
Cheplapharm Arzneimittel GmbH is a Germany-based pharmaceutical Company that markets branded drugs, medical products, supplements and cosmetics. The Company is primarily engaged in manufacturing of wide range of drugs such as: ETOPOPHOS, FUNGIZONE, VISUDYNE among others. It invests worldwide in well-established pharmaceutical brands which have been developed and introduced by research-based pharmaceutical companies. It's Primary therapeutic areas are Cardiology, Gastroenterology, Gynecology, Hematology, Immunology, Infectiology, Metabolic disorders, Neuropsychiatry, Oncology and Ophthalmology. The Company serves customers worldwide.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
---YesYesYes-

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
--Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer SebastianBraun 1/1/2004 1/1/2004
Chief Executive Officer EdeltraudLafer 3/1/2021 3/1/2021
Chief Financial Officer KiaParssanedjad 1/1/2022 1/1/2022
Chief Operating Officer PatrickKoenig 1/1/2021 1/1/2021
Chief Scientific Officer BiancaJuha 1/1/2013 1/1/2013

General Information
Fax Number: +49 38343914119


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, April 22, 2024